Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
266 articles
Multi-omic analysis reveals GLP-1 receptor agonists counter aging processes across multiple organ systems and biological pathways.
Plongée approfondie dans les mécanismes de la protéine de découplage 1, le contrôle par le système nerveux sympathique, et les stratégies thérapeutiques pour la santé métabolique et la longévité.
New research reveals how SEC16B protein regulates glucose homeostasis by controlling insulin secretion in pancreatic beta cells.
Novel GLP-1 analogue NNC5840 achieves greater weight reduction than semaglutide by optimizing receptor signaling bias rather than potency.
Large NHANES study shows TyG-ABSI index better predicts cardiovascular disease and death in metabolic syndrome patients than standard measures.
New review exposes stark disparities in diabetes care across Asia-Pacific, from insulin access to advanced technologies like CGM and pumps.
Foundayo and Zepbound receive rapid FDA approval for chronic weight management in adults with obesity or weight-related conditions.
Comprehensive review reveals hexokinase method as the most precise technique for glucose testing in clinical laboratories.
Systems analysis of Kenya's diabetes care exposes interconnected failures across governance, workforce, and financing that block quality treatment.
Large-scale protein analysis enhanced diabetes risk prediction by 23-29%, offering new tools for early prevention strategies.
New study shows CGMs improve blood sugar control and birth outcomes compared to traditional glucose testing during pregnancy.
NIH study identifies metabolic mechanism behind controversial skin condition and demonstrates successful treatment with mitochondrial complex I inhibitors.
